ÄãºÃ£¬»¶Ó­À´µ½¾­¹ÜÖ®¼Ò [µÇ¼] [×¢²á]

ÉèΪÊ×Ò³ | ¾­¹ÜÖ®¼ÒÊ×Ò³ | Êղر¾Õ¾

ÐźÅתµ¼ºÍת¼»î»¯Òò×Ó-3ÔÚ´óÊó¼±ÐÔ·ÎËðÉËÖбí´ïµÄÑо¿_ҩѧרҵ±ÏÒµÂÛÎÄ

·¢²¼Ê±¼ä£º2015-01-23 À´Ô´£ºÈË´ó¾­¼ÃÂÛ̳
ÐźÅתµ¼ºÍת¼»î»¯Òò×Ó-3ÔÚ´óÊó¼±ÐÔ·ÎËðÉËÖбí´ïµÄÑо¿_ҩѧרҵ±ÏÒµÂÛÎÄ ¹­Çå÷£¬ÈÎÎÄϼ£¬ÕÔ Ó¥£¬Àǿ£¬Áõ׿À­¡¾ÕªÒª¡¿ Ä¿µÄ ̽ÌÖ´óÊó¼±ÐÔ·ÎËðÉË£¨ALI£©¹ý³ÌÖУ¬ÐźÅתµ¼ºÍת¼»î»¯Òò×Ó-3£¨STAT3£©µÄ»î»¯¹æÂÉ£¬¼°ÆäÓëϸ°ûÒò×Ó°×½éËØ-6£¨IL-6£©µÄÏà¹ØÐÔ¡£·½·¨ ½¡¿µ´ÆÐÔWistar´óÊó£¨190¡À10£©g 50Ö»£¬Ëæ»ú·ÖΪÉúÀíÑÎË®(NS)×é(10Ö»)£¬Î²¾²Âö×¢ÉäNS£¬2hºó´¦ËÀ£»LPSÄ£ÐÍ×飨40Ö»£©£¬Î²¾²Âö×¢ÉäÄÚ¶¾ËØ£¨LPS£©£¨5mg/kg£©£¬·Ö±ðÓÚ×¢ÉäLPSºó1¡¢2¡¢4¡¢6hʱȡ²Ä¡£Ô­Î»ÔÓ½»·¨²â¶¨·Î×éÖ¯ÖÐSTAT3µÄ»ùÒò±í´ï£¬·ÅÃâ·¨¼ì²âѪºÍ·ÎÅݹàÏ´Òº£¨BALF£©ÖÐIL-6µÄŨ¶È£¬½«¶þÕß½øÐÐÏà¹ØÐÔ·ÖÎö¡£½á¹û ¼±ÐÔ·ÎËðÉ˺ó£¬ÔÚ¶àÖÖ·Îϸ°ûÖоù¿É¹Û²ìµ½STAT3µÄ»ùÒò±í´ïÔö¼Ó£¬°üÀ¨·ÎÅÝÉÏƤϸ°û¡¢Ö§Æø¹ÜÉÏƤϸ°û¡¢Ñª¹ÜÄÚƤϸ°ûÒÔ¼°Ñ×ÐÔϸ°û£»Õý³£·Î×éÖ¯STAT3»ùÒòÈõ±í´ï£¬LPSËðÉ˺ó·Î×éÖ¯ÖÐSTAT3µÄ»ùÒò±í´ïÖð½¥Ôö¸ß£¬4h´ï·åÖµ£¬ËæºóÆäˮƽÖð½¥Ï½µ£¬Ñª¼°BALFÖÐIL-6µÄŨ¶È±ä»¯ÓëSTAT3µÄ»ùÒò±í´ïÏàÒ»Ö£¬ÇÒ¶þÕßÖ®¼äÃ÷ÏÔÏà¹Ø¡£½áÂÛ ÔÚ¼±ÐÔ·ÎËðÉ˵ÄÔçÆÚ°éËæÓÐÐźÅתµ¼JAKs- STAT3ͨ·µÄ¼¤»î£¬IL-6ÊÇSTAT3ͨ·»î»¯µÄ»úÖÆÖ®Ò»¡£ ¡¾¹Ø¼ü´Ê¡¿ ÐźÅתµ¼£»×ªÂ¼»î»¯Òò×Ó-3£»¼±ÐÔ·ÎËðÉË£»°×ϸ°û½éËØ-6 ¡¾Abstract¡¿ Objective To investigate the activation law of signal transducers and activators of transduction-3(STAT3) and whether cytokine IL-6 can activate STAT3 in acute lung injury (ALI) of rats. Methods 50 female Wistar rats (190¡À10g) were randomly divided into NS group£¨n=10£©£¬ALI groups(n=40). After intravenous injection of endotoxin (5mg/kg) from tail vein£¬animals were killed at 1th£¬2th£¬4th and 6th hour. Detection of STAT3 gene expression of lung tissue with in situ hybridization(ISH) and measurement of the concentration of IL-6 in blood and BALF with radioimmunoassasy.Results LPS treatment resulted in STAT3 activation throughout the resident lung cells£¬as well as in the recruited inflammatory cells. STAT3mRNA expression in lung constitution increased gradually£¬peaked at 4th hour and started to decrease at 6th hour. The change of IL-6 concentration in blood and BALF is consistent with the changes of STAT3mRNA expression£¬and the two is positively correlated. Conclusion The experimental result shows the JAK-STAT3 pathway is activated at early phase of ALI; IL-6 may activate STAT3 pathway at early phase of ALI. ¡¾Key words¡¿ signal transducers£»activators of transduction-3; acute lung injury; IL-6 ÐźÅתµ¼ºÍת¼»î»¯Òò×Ó£¨signal transducers and activators of transduction£¬STAT£©¼Ò×å×÷ΪDZÔÚµÄϸ°ûת¼Òò×ӽ鵼Á˶àÖÖÉúÎïѧЧӦ£¬ÆäÖÐSTAT3ÊÇ STAT¼Ò×åµÄÖØÒª³ÉÔ±£¬Ëü¿ÉÒÔ±»¶àÖÖϸ°ûÒò×ÓºÍÉú³¤Òò×ӻ¡£½üÄêÀ´¶ÔÐźÅתµ¼µÄÑо¿·¢ÏÖ£¬STATµ°°×¼Ò×åÔÚ¼±ÐÔ·ÎËðÉËʱÓбí´ï£¬ÆäÖÐSTAT3µ°°×ÊÇÒÔÒ»ÖÖ¿¹Ñ×ÐÔµ°°×´æÔÚ£¬¶Ô¼±ÐÔ·ÎËðÉËÆðµ½Ò»¶¨µÄ×ÔÉí±£»¤×÷ÓãÛ1£Ý¡£±¾ÊµÑéÒÔÄÚ¶¾ËØ£¨LPS£©Ôì³É¼±ÐÔ·ÎËðÉËÄ£ÐÍ£¬À´¹Û²ì·Î×éÖ¯ÖÐSTAT3µÄ»ùÒò±í´ï¹æÂɼ°Æä¿ÉÄܵļ¤»îÒò×Ó¡£ 1 ²ÄÁÏÓë·½·¨ 1.1 ²ÄÁÏ ´ÆÐÔ½¡¿µWistar´óÊó£¬ÓÉɽÎ÷Ò½¿Æ´óѧʵÑ鶯ÎïÖÐÐÄÌṩ£»ÄÚ¶¾ËØ£¨lipopolysaccharide£¬L-2880 055£º B5£©¡¢DEPCˮΪÃÀ¹úSigma¹«Ë¾²úÆ·£»STAT3ԭλÔÓ½»ÊÔ¼ÁºÐ¡¢DABÏÔÉ«Òº¼°Ô­Î»ÔÓ½»¸Ç²£Æ¬¾ù¹º×ÔÎ人²©Ê¿µÂ¹«Ë¾£»µâ£¨125I£©IL-6·ÅÃâÊÔ¼ÁºÐ¹º×Ô±±¾©±±ÃⶫÑÅÉúÎï¼¼ÊõÑо¿Ëù¡£ 1.2 ·½·¨ 1.2.1 ¶¯Îï·Ö×é¼°Ä£ÐÍ 50Ö»´ÆÐÔ½¡¿µWistar´óÊó£¨190¡À10£©g£¬Ëæ»ú·ÖΪ5×é¡£ÓÃ2%Îì°Í±ÈÍ×ÄÆ40mg/kg¸¹Ç»Âé×í£º£¨1£©ÉúÀíÑÎË®¶ÔÕÕ×飨10Ö»£©£º β¾²Âö×¢ÉäÉúÀíÑÎË®£¨2ml/kgÌåÖØ£©£¬Ô¼2hºó´¦ËÀ£¬²É¼¯±ê±¾£»£¨2£©LPSÄ£ÐÍ×飨40Ö»£©£ºÎ²¾²Âö×¢ÉäLPS£¨5mg/kgÌåÖØ£©£¬·Ö±ðÓÚ×¢ÉäLPS 1¡¢2¡¢4¡¢6hºó»îɱ´óÊó²É¼¯ÑùÆ·£¬¸÷ʱÏàµã¸÷10Ö»¡£¸÷×鶯ÎïÆʸ¹£¬¸¹Ö÷¶¯ÂöȡѪºó´¦ËÀ¡£ÁôȡѪÇ嶳´æÓÚ-20¡æ±ùÏä±£´æ±¸Ó᣾­Æø¹Ü²åÈë12ºÅÕëÍ·¹ÜÓÚ×ó²à·Î×éÖ¯£¬ÒÔ4¡æÉúÀíÑÎË®·Ö±ð°´1.5¡¢1¡¢1ml¹àÏ´3´Î£¬»ºÂý»Ø³é¹àÏ´Òº£¬ÒÔ1500r/minÀëÐÄ10min£¬È¡ÉÏÇ嶳´æÓÚ-70¡æ±ùÏä±£´æ´ý²âIL-6Öµ¡£È¡ÓÒÏ·Î×éÖ¯Ô¼0.5cm¡Á0.5cm´óС×éÖ¯¿é£¬¹Ì¶¨ÓÚ10%ÖÐÐÔ¼×È©£¬Ê¯À¯°üÂñºóÐУ¨HE£©È¾É«¼°²¡Àíѧ¹Û²ì¡£È¡ÓÒÖзÎ×éÖ¯Ô¼0.3cm¡Á0.2cm´óС×éÖ¯3~4¿é£¬¹Ì¶¨ÓÚ4%¶à¾Û¼×È©£¨ÄÚº¬0.1ÞPCË®£©£¬6hºóʯÀ¯°üÂñ¡£ 1.2.2 ԭλÔÓ½»¼ì²âSTAT3mRNAµÄ±í´ï 4%¶à¾Û¼×È©¹Ì¶¨µÄ·Î×éÖ¯¾­Ê¯À¯°üÂñÇÐƬ£¬ÖÃÓÚ¾­10%¶à¾ÛÀµ°±ËᣨÄÚº¬0.1% DEPCË®£©´¦ÀíµÄÔز£Æ¬ÉÏ£¬ÇÐƬºñ¶È6¦Ìm£¬60¡æºæ¿¾¹ýÒ¹¡£³£¹æÍÑÀ¯ÖÁË®£»3%¹ýÑõ»¯ÇâÈÜÒº·õÓý10min£¬Ïû³ýÄÚÔ´ÐÔ¹ýÑõ»¯Çâø»îÐÔ£»3%èÛéÚËáÐÂÏÊÅäÖõÄθµ°°×øÊÒδ¦Àí20min£»µÎ¼ÓÔ¤ÔÓ½»Òº£¬40¡æ·õÓý4h£»µÎ¼ÓÔÓ½»Òº£¬ÒÔԭλÔÓ½»×¨ÓøDz£Æ¬¸²¸Ç£¬ÊªºÐ40¡æÎÂÏä·õÓý¹ýÒ¹£»µÎ¼ÓÉúÎïËØ»¯Ê󿹵ظßÐÁ£¬37¡æ 60min£»µÎ¼ÓSABC£¬37¡æ 20min£»µÎ¼ÓÉúÎïËØ»¯¹ýÑõ»¯Îïø£¬37¡æ 20min£»DABÈÜÒºÏÔÉ«23min£¬ÕôÁóË®³ä·ÖÏ´µÓ£»ËÕľËØÇá¶È¸´È¾£¬¾Æ¾«ÍÑË®£¬¶þ¼×±½Í¸Ã÷£¬ÖÐÐÔÊ÷½º·âƬ¡£ÒõÐÔ¶ÔÕÕÒÔPBS»º³åÒº´úÌæÔÓ½»Òº£¬ÆäËû²½Öè²»±ä¡£ 1.3 ½á¹ûÅж¨ ÑôÐÔȾɫΪϸ°û½¬ÄÚ×Ø»ÆÉ«×ÅÉ«¿ÅÁ££¬Ï¸°ûºËÄÚÉÙÁ¿×ÅÉ«¡£²ÉÓÃMias-2000ϸ°ûͼÏñ·ÖÎöÒǶÔȾɫ½á¹ûÐа붨Á¿·ÖÎö£¬ÔÚÏÔ΢¾µ(¡Á200)ÏÂÒÔÏàͬÍⲿÌõ¼þ(ÁÁ¶È)ÉãÈ¡bmpͼÏñ£¬Ã¿ÕÅÇÐƬÉã10¸±£¬STAT3mRNAԭλÔÓ½»Í¼ÏñÐÐƽ¾ù¹âÃܶÈÖµ²â¶¨£¬Ã¿ÕÅÇÐƬȡ¾ùÖµ¡£ 1.4 Ѫ¼°Ö§Æø¹Ü·ÎÅݹàÏ´ÒºÖÐIL-6µÄ²â¶¨ ½«¶³´æµÄѪÇå¼°Ö§Æø¹Ü·ÎÅݹàÏ´ÒºÖÃÓÚÊÒÎÂϸ´ÈÚ¡¢»ìÔÈ£¬²ÉÓ÷ÅÃâ·¨¼ì²â£¬²Ù×÷Ñϸñ°´ÕÕÊÔ¼ÁºÐ˵Ã÷Êé¡£¸ÃÊÔ¼ÁºÐÁéÃô¶È£º£¼50pg/ml¡£ 1.5 ͳ¼Æѧ·ÖÎö ʵÑéÊý¾Ý²ÉÓÃSPSS 13.0Èí¼þ°ü½øÐзÖÎö£¬Êý¾ÝÒÔ£¨x¡Às£©±íʾ£¬²ÉÓÃq¼ìÑé¡¢·½²î·ÖÎöºÍÖ±ÏßÏà¹Ø·ÖÎö£¬P
¾­¹ÜÖ®¼Ò¡°Ñ§µÀ»á¡±Ð¡³ÌÐò
  • ɨÂë¼ÓÈë¡°¿¼ÑÐѧϰ±Ê¼ÇȺ¡±
ÍƼöÔĶÁ
¾­¼ÃѧÏà¹ØÎÄÕÂ
±êÇ©ÔÆ
¾­¹ÜÖ®¼Ò¾«²ÊÎÄÕÂÍƼö